SILVERARC CAPITAL MANAGEMENT, LLC CTI BioPharma Corp. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$5.72M
portfolio value

SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-2.51%
quarter

CTI BioPharma Corp. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -28.74% -396.59K shares -2.51M $5.82 983.51K
Q2 2022 share Decrease -38.66% -869.88K shares -2.26M $5.97 1.38M
Q1 2022 share Increase +51.63% 766.17K shares 6.82M $4.67 2.25M
Q4 2021 share Increase 0.00% 1.48M shares 3.68M $2.48 1.48M